CTOs on the Move

Milestone Pharmaceuticals

www.milestonepharma.com

 
Milestone was founded in 2005 with the underlying concept to base its drug development programs on clinically validated mechanisms of action in order to mitigate as much drug development risk as possible. The company has raised a total of $34 million in venture capital financing since 2006. At its founding, the company assembled a panel of leading pharmaceutical R&D executives (“drug hunters”) each with an average of 30 years experience in drug development. The drug hunters proposed NCE projects based on clinically proven science to form the basis of Milestone’s drug development programs. Milestone has a seasoned management team with experience in ...
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.milestonepharma.com
  • 1111 Dr Frederik Philips Blvd Suite 420
    Saint Laurent, QC CAN H4M 2X6
  • Phone: 514.336.0444

Executives

Name Title Contact Details
Debbie Everidge
 Vice President Information Technology Profile

Funding

Milestone Pharmaceuticals raised $17M on 06/15/2015
Milestone Pharmaceuticals raised $55M on 08/01/2017
Milestone Pharmaceuticals raised $80M on 10/25/2018

Similar Companies

Health Supply US

Health Supply US provides America’s leading health care facilities and first responder networks and governments with Personal Protective Equipment (PPE), Sanitizers, and COVID Testing Kits among other devices and supplies. We service government at all ...

BioXcel Therapeutics

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. The company`s drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. The company`s two most advanced clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.

Biochemics Inc

Biochemics Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Global Medical Institutes

Global Medical Institutes is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innomar Strategies

Innomar Strategies, a part of AmerisourceBergen, is Canada`s leading patient support provider for specialty pharmaceuticals. We deliver end-to-end support solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient assistance programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to best-in-class care, Innomar Strategies ensures patients are supported throughout their treatment journey every step of the way.